Navigation Links
Cell Therapeutics, Inc. Announces Issuance of 2011 Convertible Senior Notes and Common Stock Warrants to a Single Institutional Investor
Date:6/11/2008

SEATTLE, June 12 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (Nasdaq and MTA: CTIC) today announced that a single institutional investor has agreed to purchase, for $23 million, newly issued 15% Convertible Senior Notes due 2011, with an initial conversion price of $0.79 per share, and a warrant to purchase approximately 14.6 million shares of common stock with an exercise price of $0.95 per share.

This transaction constitutes a partial exercise of a previously granted warrant right for the investor to purchase up to $67.5 million of such unit securities, leaving the investor with the right to purchase up to $44.5 million of additional securities in the future. The Company and the investor have amended their original April 30, 2008 agreements to change from 12.5% to 15% the interest rate on the Notes within these units, but the purchase price for the securities, the conversion price of the notes and the exercise price for the warrants remain unchanged.

The new Notes have a $23 million initial principal balance and feature a make-whole provision entitling the holder, upon any conversion of the Notes, to receive the interest payable through scheduled maturity, less any interest paid before conversion. The Company expects to receive net proceeds of approximately $12.65 million from this transaction. The Notes will rank equal in right of payment with all existing and future unsecured senior indebtedness of CTI.

The Company intends to use approximately $11.0 million of the net proceeds from this transaction to retire upon maturity the remaining balance of its 2008 convertible notes due June 15, 2008, together with accrued interest.

This press-release contains forward-looking statements that involve a number of risks and uncertainties, the outcome of which could materially and/or adversely affect future results. The risks and uncertainties include that the investor may choose not to exercise any of the remaining warrants issued in
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
2. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
3. ARYx Therapeutics, Inc. Files Registration Statement for Initial Public Offering
4. Nile Therapeutics, Inc. Adds to Executive Management Team
5. Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer
6. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
7. Cell Therapeutics, Inc. (CTI) Announces 2007 Annual Shareholders Meeting Results
8. Northwest Biotherapeutics, Inc. Announces Appointment of Chief Financial Officer
9. Nile Therapeutics, Inc. to Present at Upcoming BIO Investor Forum
10. Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event
11. Cell Therapeutics, Inc. (CTI) BIO Presentation to Be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2008)... JERSEY CITY, New Jersey, December 5,/PRNewswire-...SG ), an,innovative molecular diagnostic company ...y its consolidated financial results for the quart...ts. , The company recorded revenues for the...s were recorded from the date of acquisition of Pa...
(Date:12/5/2008)... /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYS... company that identifies, develops and commerciali..., today reported that Oncoscience AG, the European...YM BioSciences Inc., has withdrawn its application...ting authorization of nimotuzumab. Withdrawal of a...
(Date:12/5/2008)...PRNewswire-Asia-FirstCall/ -- China Sky One Medica...) (Nasdaq: CSKI ), a leading,fully integrated p...rugs in,the People,s Republic of China ("PRC"), a...EO and President of China Sky One Medical took par...The China Perspective. , As a well-known ph...
(Date:12/4/2008)...wire-FirstCall/ -- Cell Therapeutics, Inc. ("CTI",...nounced that a single,institutional investor shal...Convertible Senior Notes due 2011 (the "Notes"), w... The new Notes would have a $32.65 million init...ovision entitling the holder, upon any conversion ...
Breaking Biology Technology:Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 2Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 3Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 4Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 5Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 6Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 7Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 8Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 9Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 10YM BIOSCIENCES PROVIDES EU REGULATORY UPDATE 2YM BIOSCIENCES PROVIDES EU REGULATORY UPDATE 3China Sky One Medical, Inc. Interviewed in The China Perspective 2China Sky One Medical, Inc. Interviewed in The China Perspective 3Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $32.65 Million of Senior Convertible Notes 2Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $32.65 Million of Senior Convertible Notes 3
... The University of Wisconsin-Madison professor of ...helped forge some of the early international chann...networks are heading and its all about finding th...g power. , ,Before conducting an interview with WT...ational Science Foundation , Landweber spoke at th...
... some competition soon. A coalition of research a...king plans for an incubator for start-up biotech c...is straining to fit new companies in, said represe...liance, so the area needs more room to attract com...velopment at the research park, which includes an ...
...scale. Source: Imago The Nanostructural Analysis...y for nanotechnology research, said it has commiss...Scientific Instruments Corp. , ,NANO officials sa...Australian and international researchers can use a...o analyse materials down to the atomic scale using...
...red some promising advances in Wisconsin technolog...attention, and the state has set in motion public ...ience research forward. , ,In other news, the Wisc...rate, here are some of our favorite stories of 200...inue to push IT forward and bring in honors. Our ...
Other Biology Technology:Landweber on networks, open source, and NSF budget cuts 2Landweber on networks, open source, and NSF budget cuts 3Landweber on networks, open source, and NSF budget cuts 4Milwaukee research alliance sees need for incubator 22004 in review: Editors picks 22004 in review: Editors picks 3
(Date:12/3/2008)...DFORD/SOMERVILLE, Mass. Natural changes in voltag...em cells are a powerful controlling factor in the ...ccording to research published by Tufts University...delacruz, Professor of Biology Michael Levin, and ...orresponding author) published their paper "Membr...
(Date:12/3/2008)... Chase, MDDiets that are high in protein and cerea...ch may increase calcium excretion and weaken bones...n in The Endocrine Society,s Journal of Clinical ...und that increasing the alkali content of the diet... vegetables has the opposite effect and strengthen...
(Date:12/2/2008)...g an imperfect body may come with some substantial...le in the December issue of Current Anthropology ...onger, more competitive and better able to deal wi...ips to the waist, according to Elizabeth Cashdan, ... societies and situations where women are under pr...
(Date:12/2/2008)..., Lithuania, Dec. 2 Neurotechnolog...of biometric identification,technologies, today a...cher,SDK multi-biometric technology to identify d...base. The Bangladesh Voter Registration Project re...etric face and fingerprint technology.,After eval...
Breaking Biology News(10 mins):New 'control knobs' for stem cells identified 2Calcium and vitamin D may not be the only protection against bone loss 2Why the 'perfect' body isn't always perfect 2Bangladesh Voter Registration Project Now Using MegaMatcher Biometric Technology to Detect and Prevent Duplicate Registrations 2Bangladesh Voter Registration Project Now Using MegaMatcher Biometric Technology to Detect and Prevent Duplicate Registrations 3Anthera Pharmaceuticals Inc Appoints Donald Santel to Board of Directors 4945 1Anthera Pharmaceuticals Inc Appoints Donald Santel to Board of Directors 4945 2Video 3A Grin Big With an Award Winning Smile 4941 1Video 3A Grin Big With an Award Winning Smile 4941 2Video 3A Grin Big With an Award Winning Smile 4941 3Beckman Coulter Signs Agreements With Amerinet Inc 3B Ten Year Partnership Extended for Another Three Years 4937 1Beckman Coulter Signs Agreements With Amerinet Inc 3B Ten Year Partnership Extended for Another Three Years 4937 2Beckman Coulter Signs Agreements With Amerinet Inc 3B Ten Year Partnership Extended for Another Three Years 4937 3Pharmos Restructures Operations in Israel 4933 1Pharmos Restructures Operations in Israel 4933 2Pharmos Restructures Operations in Israel 4933 3
...ting symbiotic relationship between a wasp species...ionship that potentially sheds light on how bacter...s in defensive mechanisms against other microbes. ...ground-nesting wasp, the European beewolf, harbors... its antennae and that females utilize these bacte...
...only in germ-line cells results in infertility in ...rom researchers at the University of Pennsylvania ...f Human Reproduction in Penn,s Center for Research...s say that these investigations point the way to a... They report their findings in this week,s online ...
...een indoctrinated into believing that our senses, ...by a communication network of brain cells, or neur...emical message called a neurotransmitter. Either n...eighboring cell, thereby triggering an electrical ...spatch a signal that quells a neuron,s activity. S...
...roduction includes a special paper by a team of Sp...d in mice results in shorter life expectancy and r...effects of late maternal age in women, such as abn...e well known. However, other potential negative ef...en only anecdotal. , In what the editors of Biolo...
Other Biology News:Symbiotic bacteria protect hunting wasps from fungal infestation 2Of mice and men's (and women's) contraceptives 2Researchers make surprise discovery that some neurons can transmit three signals at once 2Researchers make surprise discovery that some neurons can transmit three signals at once 3
... of robotic workstations is designed for laborator... automation platform for routine sample preparatio...res, improving throughput, process consistency and...tware allows you to control the robotic and liquid...
Mouse monoclonal antibody to CDC2L5 - cell division cycle 2-like 5 (cholinesterase-related cell division controller)
FluoroGuard Antifade Reagent from Bio-Rad
Mouse polyclonal antibody to GRID2 - glutamate receptor, ionotropic, delta 2
Biology Products: